Frequency and prediction of deep uterine involvement in advanced high‐grade epithelial ovarian cancer: is uterine preservation an option?. Issue 2 (February 2021)
- Record Type:
- Journal Article
- Title:
- Frequency and prediction of deep uterine involvement in advanced high‐grade epithelial ovarian cancer: is uterine preservation an option?. Issue 2 (February 2021)
- Main Title:
- Frequency and prediction of deep uterine involvement in advanced high‐grade epithelial ovarian cancer: is uterine preservation an option?
- Authors:
- Perri, Tamar
Harel, Gal
Dadon, Tal
Mor‐Sasson, Aya
Yagel, Itai
Ben‐Baruch, Gilad
Korach, Jacob - Abstract:
- ABSTRACT : Introduction : Hysterectomy is traditionally part of the surgical treatment for advanced high‐grade epithelial ovarian carcinomas, although the incidence of uterine involvement has not been fully investigated. Some young patients with advanced high‐grade epithelial ovarian carcinomas want uterine preservation. We aimed to determine the frequency of non‐serosal (deep) uterine involvement in patients with high‐grade epithelial ovarian carcinomas and to establish predictive factors for such involvement. Methods : A retrospective cohort study was performed of 366 consecutive patients with advanced high‐grade epithelial ovarian carcinomas who had surgery between January 2012 and December 2019. Data collected included demographic and clinical details, and surgical and pathological reports to determine macroscopic and microscopic deep uterine involvement. The characteristics of the patients with and without deep uterine involvement were compared and univariate and multivariate Cox proportional hazard models were used to assess correlations and determine risk factors. Results : A total of 311 patients were included in the final analysis. The mean age was 62±11.6 years, with 32 (10.3%) being younger than 45. Most (92.3%) had serous carcinoma. Uterine involvement, excluding superficial (serosa‐only), was present microscopically in 194 patients (62.4%) but was detected macroscopically at surgery in only 166 patients. Deep involvement was missed at surgery in 28 patientsABSTRACT : Introduction : Hysterectomy is traditionally part of the surgical treatment for advanced high‐grade epithelial ovarian carcinomas, although the incidence of uterine involvement has not been fully investigated. Some young patients with advanced high‐grade epithelial ovarian carcinomas want uterine preservation. We aimed to determine the frequency of non‐serosal (deep) uterine involvement in patients with high‐grade epithelial ovarian carcinomas and to establish predictive factors for such involvement. Methods : A retrospective cohort study was performed of 366 consecutive patients with advanced high‐grade epithelial ovarian carcinomas who had surgery between January 2012 and December 2019. Data collected included demographic and clinical details, and surgical and pathological reports to determine macroscopic and microscopic deep uterine involvement. The characteristics of the patients with and without deep uterine involvement were compared and univariate and multivariate Cox proportional hazard models were used to assess correlations and determine risk factors. Results : A total of 311 patients were included in the final analysis. The mean age was 62±11.6 years, with 32 (10.3%) being younger than 45. Most (92.3%) had serous carcinoma. Uterine involvement, excluding superficial (serosa‐only), was present microscopically in 194 patients (62.4%) but was detected macroscopically at surgery in only 166 patients. Deep involvement was missed at surgery in 28 patients (14.4%), including parametrial involvement (n=18), parametria plus cervix (n=2), cervical involvement (n=3), endometrium (n=3), and myometrium (n=2). Multivariate analysis identified factors associated with deep uterine involvement including residual disease at surgery (HR 2.43, 95% CI 1.13 to 4.48; p=0.004) and CA125 >1000 U (HR 1.8, 95% CI 1.09 to 2.94; p=0.02). Conclusions : The incidence of deep uterine involvement in high‐grade epithelial ovarian carcinomas is high. It can be diagnosed in most but not all cases on gross examination at surgery and is associated with residual disease and CA125 >1000 U. Patients who desire uterine preservation should be advised on an individual basis, given these factors and the operative findings. … (more)
- Is Part Of:
- International journal of gynecological cancer. Volume 31:Issue 2(2021)
- Journal:
- International journal of gynecological cancer
- Issue:
- Volume 31:Issue 2(2021)
- Issue Display:
- Volume 31, Issue 2 (2021)
- Year:
- 2021
- Volume:
- 31
- Issue:
- 2
- Issue Sort Value:
- 2021-0031-0002-0000
- Page Start:
- Page End:
- Publication Date:
- 2021-02
- Subjects:
- cystadenocarcinoma -- ascitic fluid -- gynecologic surgical procedures -- surgical procedures -- operative -- hysterectomy
Generative organs, Female -- Cancer -- Periodicals
616.99465 - Journal URLs:
- http://journals.lww.com/ijgc/pages/default.aspx ↗
http://www3.interscience.wiley.com/journal/118544021/toc ↗
https://ijgc.bmj.com/ ↗
http://journals.lww.com ↗ - DOI:
- 10.1136/ijgc-2020-001850 ↗
- Languages:
- English
- ISSNs:
- 1048-891X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.273500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 17767.xml